心房動 カテーテル除去 vs 医療療法と心理的苦痛:ランダム化臨床試験
Ahmed M Al-Kaisey1,2,3, Ramanathan Parameswaran1,2,3, Christina Bryant4
1Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
JAMA
|September 12, 2023
まとめ
カテーテル切除は,治療のみと比較して,心房細動患者の不安やうつ状態を有意に改善しました. このアプローチは 症状のあるAFで より良い精神的健康結果を もたらします
科学分野:
- 心臓病科
- 精神科
背景:
- 心房細動 (AF) カテーテル切除が精神的健康に与える影響は十分に理解されていません.
- 症状のあるAFはしばしば心理的苦痛と共存し,生活の質に影響します.
研究 の 目的:
- 心理的ストレスマーカーの改善における AF カテーテル除去と医療療法の効果を比較する.
- AF患者における不安やうつ症状に対するアブレーションの影響を評価する.
主な方法:
- ランダム化試験 (REMEDIAL研究) で,症状のあるAFの参加者は100人でした.
- 参加者はAFカテーテル除去 (n=52) または医療療法 (n=48) に割り当てられました.
- 主要アウトカム: 12ヶ月の病院不安およびうつ病スケール (HADS) スコア; 二次的アウトカムにはBDI-IIと重度の苦痛の流行が含まれています.
主要な成果:
- カテーテル除去グループは,医療療法グループと比較して,6ヶ月と12ヶ月でHADSスコアが有意に低下した.
- 重度の心理的苦痛の発生率は6ヶ月と12ヶ月の両方で減った.
- アブレーション群では,不安,うつ病のHADSスコア,およびBDI- IIスコアで有意な改善が見られた.
結論:
- AFカテーテル切除は不安やうつ病の心理的な症状に 顕著な改善をもたらします
- 医学的な治療だけでは,AF患者の精神的健康状態の改善に類似した効果は示されなかった.
- カテーテル切除は,心理的な苦痛を経験している症状のあるAF患者のための適切な治療法です.
関連する概念動画
Dysrhythmias VI: Management of Dysrhythmias
19
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
19
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
40
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
40
Acute Coronary Syndrome IV: Interprofessional Care
11
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Electroconvulsive Therapy
68
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
68


